Current Status of Delta in the United States
As of the most recent nationally reported data, Delta lineage viruses remain detectable across multiple regions of the United States, though prevalence and sequencing coverage vary by jurisdiction. In some areas, Delta continues to cause a measurable share of cases, often where population immunity is lower or sequencing is less frequent. The public health significance of Delta today centers on its sustained circulation in pockets of under-vaccinated or vulnerable communities, its potential to drive localized surges, and its role as a baseline lineage in ongoing genomic surveillance. Understanding where Delta stands requires looking at how often sequences are uploaded to GISAID, what proportion of sequences are still Delta relative to Omicron sublineages, and where localized clusters are reported by state and territorial health departments.
What It Means for Public Health and Variants of Concern
How Delta Compares to Current Dominant Variants
Delta (SARS-CoV-2 lineage B.1.617.2) was the dominant variant during mid-2021 in the United States, driving substantial waves of infection and hospitalization before being displaced by Omicron and its successive sublineages in 2022. From a public health perspective, Omicron and its descendants now account for nearly all sequenced cases, but Delta has not been completely eliminated. Where it is detected today, it is usually at low levels, often in combination with other lineages or in settings with lower vaccination and booster coverage. This shift matters because Delta’s evolutionary trajectory is distinct from Omicron: it is less antigenically matched to existing immunity, and some studies suggest differences in severity and vaccine effectiveness compared with early Omicron sublineages. Continued genomic surveillance remains important to detect any re-emergence or recombination involving Delta and circulating Omicron lineages.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Primary Lineage | B.1.617.2 | GISAID, Nextstrain |
| Current US Prevalence | Low, localized detection; Omicron descendants dominate sequences | CDC Nowcast, state health department reports |
| Notable Traits | Higher transmissibility than pre-Alpha lineages; partial immune escape relative to early vaccine strain | Peer-reviewed studies, WHO reports |
| Public Health Relevance Today | Surveillance baseline; potential for localized spread in under-vaccinated areas | CDC, state epidemiologist updates |
| Data Lag | Sequencing and reporting typically lag by 1–3 weeks | CDC data notes and state dashboards |
Where to Find Specific, Up-to-Date Information
Because Delta is now a lower-frequency lineage, national dashboards may understate localized presence, while state and jurisdictional dashboards provide more relevant detail. The most reliable way to track where Delta is currently found includes checking CDC’s variant nowcasts and the proportion of sequences assigned to Delta relative to other lineages, reviewing state health department dashboards that break down lineages by region, and examining GISAID entries tied to US collection dates and locations. Wastewater surveillance can also signal increased circulation in a region, though it usually does not specify lineage. When reviewing these sources, note that sequencing capacity is uneven: areas with more testing, sequencing, and reporting will appear to have more Delta simply because more viruses are characterized, whereas areas with limited surveillance may have undetected or under-reported circulation.
How Delta Compares to Omicron Sublineages Today
Lineage Landscape and Surveillance
In most US jurisdictions, sequences are overwhelmingly from Omicron sublineages such as BA.2, BA.2.12.1, and current descendants. Delta accounts for a small and declining fraction of sequences nationally, but that fraction can be higher in areas with lower vaccination coverage or where wastewater signals rise. For decision-makers, this means outbreaks today are more likely to stem from Omicron lineages; however, Delta’s persistence offers insights into longer-term immunity patterns and potential shifts in population susceptibility. From a genomic perspective, Delta continues to evolve within hosts and at population scale, and any marked change in its relative frequency or in indicators like case-to-severity ratios would be monitored carefully. Understanding the interplay between Delta and Omicron helps contextualize hospitalization patterns, vaccine effectiveness estimates, and the durability of prior infection protection.
Key Data Sources and How to Read Them
Interpreting Case Counts, Proportions, and Sequencing Gaps
- CDC variant proportions and Nowcast provide national-level estimates of lineage circulation, updated weekly with a reporting lag.
- State and territorial dashboards often show lineage breakdowns by jurisdiction, with finer geographic detail than national views.
- GISAID contains raw sequences tagged by collection date and location, useful for tracking Delta’s persistence in specific regions.
- Wastewater surveillance can indicate increased viral circulation but rarely identifies Delta specifically.
- Sequencing capacity and turnaround vary, so low sequence counts do not necessarily mean zero circulation; they may reflect limited sampling.
When assessing where Delta is now, prioritize consistent trends across multiple data sources rather than single data points. A region reporting ongoing Delta detections alongside rising wastewater levels and stable Omicron trends may indicate localized, low-level persistence, whereas regions with no Delta sequences and falling wastewater levels suggest minimal current transmission of this lineage.
Implications for Community Risk and Personal Decisions
For individuals and communities, the presence of Delta today is typically relevant where local transmission remains elevated and population immunity is low. In areas with high vaccination and recent Omicron waves, Delta’s relative contribution to current case burden is small, though it can still cause severe outcomes among unvaccinated or immunocompromised people. Public health guidance generally focuses on layered protections—up-to-date vaccinations, indoor masking during periods of high community transmission, improved ventilation, and rapid testing—rather than lineage-specific measures. Understanding where Delta continues to circulate can help contextualize local risk, especially for settings with lower immunity or reduced surveillance, and reinforce the value of sustained preventive measures rather than reliance on any single variant’s dominance.